Small Intestine Part 1 Flashcards

(193 cards)

1
Q

Embryology

The duodenum arises from the

A

Junction of the foregut and midgut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Embryology

The jejunum and upper part of the ileum develop from

A

Proximal limb of the midgut loop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Embryology

The distal ileum develops from the

A

Caudal limb of the midgut loop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Microscopic anatomy

Mucosa

A

Epithelium
Muscularis mucosa
Lamina propia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Microscopic anatomy

Submucosa

A

Blood vessels
Lymphatics
Myenteric meissners plexus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Microscopic anatomy

Produce an alkaline secretion to protect against acidic gastric chyme

A

Duodenal brunners gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Microscopic anatomy

Lymph node aggregates called___________ are most prevalent in the ileum

A

Peyers patches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Layers of the small intestine

Muscularis

A

Inner - circular
Outer - longitudinal layers
Between - myenteric auerbach’s plexus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Layers of the small intestine

Single layer of mesoepithelial cells lining the exterior of the SI

A

Serosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Layers of the small intestine

Mucosa

A

Epithelium
Lamina propria
Muscularis mucosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Layers of the small intestine

Sub mucosa

A

Meissners plexus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Layers of the small intestine

Muscularis propria

A

Circular muscle
Auerbach’s plexus
Longitudinal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Layers of the small intestine

The strongest layer of the small intestine
This should be included when performing intestinal anastomoses

A

Submucosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Specific cells

Arise from pluripotential cells in the crypts of Liberkuhn and migrate to the tips of villi

A

Enterocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

About 95% of the epithelial cells are enterocytes and it is specialized for

A

Digestion and absorption of dietary nutrients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Specific cells

Found at the base of the crypts of lieberkuhn
Function include, phagocytosis
Mucosal defense
Regulation of intestinal flora
Secretion of variety antimicrobial peptides

A

Paneth cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Specific cells

Located above the peyers patches
Specialized for antigen presentation

A

Microfold M cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Specific cells

Specialized for mucous secretion

A

Goblet cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Specific cells

Specialized to produce and secrete hormones

A

Entero endocrine cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Properties of small intestine

Mucosal folds visible upon gross inspection
Also visible radio graphically and help in the distinction from the colon, which not contain them.
More prominent in the proximal intestine than in the distal small intestine.

A

Plicae circulares or valvulae conniventes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Properties of small intestine

Seen on gross examination of the small intestinal mucosa follicles.
Located in the ileum, are the most prominent and designated peyers patches

A

Aggregates of lymphoid follicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Helpful both upon gross inspection in the OR and on abdominal x rays, to differentiate between the small and large bowel

A

Plicae circulares

Colon doesn’t have

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe jejunum

A
Larger diameter
Thicker wall
More prominent plicae circulares
Few arcade 1-2
Long vasa recta
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe ileum

A

Many aracades
Short vasa recta
Fatty messentery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Innervation Para sympathetic innervation
Vagus
26
Innervation Sympathetic innervation
Splanchnic nerves
27
Innervation Provides enteric nervous system innervation
Meissners and Auerbach plexuses
28
The entire small bowel is supplied by branches of the SMA except the
Proximal duodenum Supplied by celiac trunk
29
Small bowel obstruction Foreign bodies Gallstones Meconium
Intraluminal
30
Small bowel obstruction Tumors Chronhs
Intramural
31
Small bowel obstruction Adhesion Hernias Carcinomatosis
Extrinsic
32
Small bowel obstruction The most common causes of small bowel obstruction are
``` Hernia Adhesions Volvolus Intussusception Crohns Gallstone ileus SMA syndrome Neoplasm ```
33
Small bowel obstruction Related to prior abdominal surgery account for up to 75% of the cases of small bowel obstruction
Intra abdominal adhesion
34
Small bowel obstruction Commonly due to extrinsic or invasion by advanced malignancies arising in organs other than the small bowel.
Cancer related SBO
35
Small bowel obstruction Should not be forgotten when considering the differential diagnosis of adult patients with acute or chronic symptoms of small Boswell obstruction, especially those without a history of prior abdominal surgery
Intestinal Malrotation | Midgut volvulus
36
Small bowel obstruction Rare etiology of obstruction Compression of third portion of duodenum by the superior mesenteric artery Considered in young asthenic individuals who have chronic symptoms suggestive of proximal small bowel obstruction
Superior messenteric artery syndrome
37
Small bowel obstruction Pathophysiology
Onset of obstruction Gas and fluid accumulate Intestinal activity increases
38
Pathophysiology of SBO Most of the gas that accumulates originates from
Swallowed air
39
Pathophysiology of SBO The fluid consist of
Swallowed liquids | GI secretions
40
Pathophysiology of SBO
``` Gas and fluid accumulate in lumen Intaluminal and intramural pressure rise Decrease intestinal motility Changes in luminal flora and small bowel Translocation of bacteria Impaired microvascular perfusion Intestinal ischemia Necrosis Strangulated obstruction ```
41
Small bowel obstruction Only portion of intestinal lumen is occluded Strangulation is less likely
Partial SBO
42
Small bowel obstruction Dangerous form of bowel obstruction Obstructed both proximal and distal (volvolus) Rapid progression to strangulation
Closed loop obstruction
43
Clinical presentation of SBO More prominent symptom with proximal obstructions than distal
Vomiting More feculent more establish obstruction
44
Clinical presentation of SBO Continue passage of flatus and or stool beyond 6-12 hours after onset of symptoms
Obstipation More on partial than complete obstruction
45
Clinical presentation of SBO Abdominal distention most pronounced if the site of obstruction is in the
Distal ileum
46
Clinical presentation of SBO Abdominal distention May be absent if the site of obstruction is in the
Proximal small intestine
47
Clinical presentation of SBO Bowel sound may be
Hyper active initially | But minimal bowel sounds in late
48
Clinical presentation of SBO Laboratory findings Reflect intravascular volume depletion
Hemocencentration Electrolyte abnormalities Mild leukocytes is is common
49
Features associated with strangulated SBO include
``` Tenderness Tachycardia Fever Elevated WBC Acidosis ```
50
Diagnosis of SBO Goals
Mechanical vs ileus Etiology Partial vs comple Simple vs strangulated
51
Symptoms of small bowel obstructions are
Colicky abdominal pain Nausea Vomiting Obstipation
52
Diagnosis of SBO Important elements to obtain on history
Prior abdominal operations | Presence of abdominal disorders
53
Diagnosis of SBO PE Search for
Hernias | Abdominal scars
54
Diagnosis of SBO LABS Full labs
Normal at initial stage Progression Leukocytosis Hemocencentration Electrolyte abnormalities
55
Diagnosis of SBO The stool should be checked for gross or occult blood
Presence of strangulation
56
Diagnosis of SBO Confirmed by
Radiographic examination
57
Diagnosis of SBO | Abdominal series of Radiographic evaluation
Abdomen - supine Abdomen - upright Chest - upright
58
Diagnosis of SBO Radiographic Triad
Dilated stool bowel loos >3 cm Air fluid levels Paucity of air
59
Diagnosis of SBO Radiographic Sensitivity range from
70-80%
60
Diagnosis of SBO Radiographic Specificity is low because
Mimic small bowel obstruction
61
Diagnosis of SBO CT scan Sensitivity and specificity
Sensitive - 80-90% | Specific - 70-90%
62
Diagnosis of SBO CT scan Findings
Discrete transition zone, dilation of bowel proipximally, decompression distally Intra luminal contrast that dose not pass beyond transition zone Colon containing little gas or fluid
63
Closed loop obstruction CT scan Is suggested by the presence of
U shaped or C shaped dilated bowel loop
64
Closed loop obstruction CT scan Depend on 2 things
Length of bowel segment | Orientation of the loop
65
Closed loop obstruction CT scan If we have a short closed loop oriented with the plane of imaging, we will see a
U or C shaped loop of bowel
66
Strangulated obstruction CT scan The cause of this radiologic finding was intestinal ischemia Patient was taken emergently to the operating room
Intestinal pneumatosis
67
Limitation of CT scan Detection of grade or partial small bowel obstruction
Low sensitivity
68
Other limitation of CT scan Subtle transition zone may be difficult to identify in the
Axial images obtained during CT scan
69
Standard small bowel series Although barium can be used water soluble contrast agents, such as _____________ should be used if the possibility of intestinal perforation exists.
Gastrografin
70
An x ray examination of the small intestine that looks at how the liquid contrast material moves through the small intestine
Enteroclysis
71
Enteroclysis Double contrast technique used for better assessment of
Mucosal surface and detection of small lesions
72
Enteroclysis 200 - 250 ml of barium followed by 1-2 L of a solution of ___________ in water is instilled into the proximal jejeunum via a___________
Methylcellulose | Long nasoenteric catheter
73
Treatment of SBO Trial of non operative mangy
NPO Isotonic fluid NGT Foley catheter
74
Treatment of SBO May be necessary to assist with fluid management, particularly in patients with underlying cardiac disease.
Central venous or pulmonary artery catheter monitoring
75
Treatment of SBO Given by some because of concerns that bacterial translocation may occur in the setting of small bowel obstruction;
Broad spectrum antibiotics
76
Treatment of SBO Standard therapy for complete SBO has been
Surgery
77
Treatment of SBO The goal is
Operate before the onset of irreversible ischemia
78
Treatment of SBO Others note, however, that a period of observation and NG decompression , providing
No tachycardia No tenderness No increase in white cell count
79
Conservative treatment of SBO Partial SBO Do not improve within 48 hours after initiation of non operative therapy should
Undergo surgery
80
Conservative treatment of SBO Partial SBO Patients undergoing non operative therapy should be closely monitored for signs suggestive of
Peritonitis
81
Conservative treatment of SBO Obstruction in early post operative period Greater risk for developing
PT undergoing pelvic surgery
82
Conservative treatment of SBO Obstruction in early post operative period Should considered if symptoms of intestinal obstruction occur
After initial return of bowel function If bowel function fail to return 3-5 days after surgery
83
Conservative treatment of SBO Obstruction in early post operative period
Ususally partial and rarely strangulation
84
Conservative treatment of SBO Obstruction in early post operative period Treatment A period of extended non operative therapy 2-3 weeks consisting of
Bowel rest Hydration TPN
85
Conservative treatment of SBO Obstruction in early post operative period Treatment If complete obstruction is demostrated or if signs suggestive of peritonitis are detected
Re operation should be undertaken without delay
86
Conservative treatment of SBO Carcinomatosis
Adhesion
87
Conservative treatment of SBO Carcinomatosis Recurrent malignancy
Palliative resection or bypass
88
Surgical treatment of SBO The operative procedure for small bowel obstruction varies according to the etiology of obstruction.
Adhesions are lysed Tumors are resected Hernias are reduced and repaired
89
Surgical treatment of SBO Criteria suggesting viability of bowels
Normal color Peristalsis Marginal arterial pulsations
90
Surgical treatment of SBO Used to check for pulsation flow to the bowel
Doppler probe
91
Surgical treatment of SBO Arterial perfusion can be verified by visualizing intravenously administered
Fluorescein dye
92
Surgical treatment of SBO For hemodynamic ally stable patient Should be resected and primarily anastomosis
Short lenght
93
Surgical treatment of SBO For hemodynamic ally stable patient The bowel of uncertain viability should be left intact and patient LARGE
Re explored in 24 to 48 hours in a second look operation
94
Surgical treatment of SBO Success is being reported with greater frequency Quicker recovery and less post operative discomfort Presence of bowel distention and multiple adhesion can cause these procedures
Laparoscopic surgery for SBO.
95
Prognosis of SBO
Related to the etiology
96
Prognosis of SBO Majority of patients
Do not require future re admissions
97
Prognosis of SBO Mortality
5% non strangulating elderly | 8-25% strangulated
98
Prevention of SBO
Adhesion prevention Laparoscopic surgery Seprafilm
99
Prevention of SBO Cornerstone of adhesion prevention consists of
Good surgical technique Careful handling of tissue Minimal use and exposure of peritoneum to foreign bodies
100
Prevention of SBO Hyaluran based agents Reduce incidence of post operative bowel adhesion
Seprafilm
101
Clinical syndromes caused by impaired intestinal motility | Characterized by SS of intestinal obstruction in the absence of a lesion causing mechanical obstruction
Ileus and intestinal pseudo obstruction
102
Major caused of morbidity in hospitalized patients
Ileus
103
Most frequently implicated cause of delayed discharge following abdominal operations
Post operative ileus
104
A temporary motility disorder that is reversed with time as the inciting factor is corrected
Ileus
105
Compromises a spectrum of specific disorders associated with irreversible intestinal dysmotility
Chronic intestinal pseudo obstruction
106
Pathophysiology of ileus Responsible for dysmotility
Surgical stress Inflammatory response Anesthetic or analgesics
107
Pathophysiology of ileus Post operative return of bowel function varies by
Small intestine - 1 day Stomach - 2 days Large intestine- 3-5 days
108
Pathophysiology of ileus Not reliable indicator
Bowel sounds
109
Pathophysiology of ileus More useful indicator
Passing flatus or bowel movement
110
Pathophysiology of ileus Resolution of ileus may be delayed in the presence of other factors capable of inciting ileus such as
Intra abdominal abscesses | Electrolyte abnormalities
111
Pathophysiology of ileus | Can caused by a large number of specific abnormalities affecting intestinal smooth muscle,
Chronic intestinal pseudo obstruction
112
Constitute a group of diseases characterized by degeneration and fibrosis of the intestinal muscularis propria.
Visceral myopathies
113
Encompasses a variety of degenerative disorders of the myenteric and sub mucosal plexuses
Visceral neuropathies
114
Chronic intestinal pseudo obstruction Primary causes
Familial types | Sporadic types
115
Chronic intestinal pseudo obstruction Secondary causes
``` Smooth muscle disorders Neurologic disorders Endocrine disorders Miscellaneous disorders Pharmacologic causes ```
116
Chronic intestinal pseudo obstruction Familial type
Familial visceral myopathies type 1,2&3 Familial visceral neuropathies type 1&2 Childhood visceral myopathies type 1&2
117
Clinical presentation Ileus
``` Inability to tolerate liquid Nausea Lack of flatus Vomiting Abdominal distention No bowel sounds ```
118
Clinical presentation CIPO
Variable degrees of nausea and vomiting | Abdominal pain and distention
119
Diagnosis Ileus Known to be associated with impaired intestinal motility
Opiates
120
Diagnosis Ileus Measurement of serum electrolytes abnormalities
Hypokalemia Hypocalcemia Hypomagnesemia Hypermagnesemia
121
Diagnosis Ileus Distinction between ileus and mechanical obstruction may still be difficult
Abdominal x rays
122
Diagnosis Ileus Test of choice in post operative setting
Ct scan
123
Diagnosis CIPO May be required to establish the specific underlying causes
Laparotomy or laparoscopy
124
Treatment of ileus
Limit oral intake NGT Fluid and electrolytes TPN
125
Treatment of CIPO
Palliative of symptoms Fluids Surgery should be avoided
126
Treatment of CIPO Has been associated with palliation of symptoms, however because of cardiac toxicity and reported death, restricted
Cisapride (propulsid)
127
Chrons disease Chronic, idiopathic trans mural inflammatory disease with a propensity to affect the
Distal ileum
128
Chrons disease Most common in
Female 3rd decade and 6th decade
129
Features of chrons
``` Genetic and environmental factors First degree relatives Monozygotic twins Higher socioeconomic status Smokers ``` Breast feeding protective against developing chrons
130
Pathophysiology of Chrons disease Causative agents
``` Chlamydia Listeria monocytogenes Pseudomonas species Reovirus Mycobacterium para tuberculosis ```
131
Pathophysiology of Chrons disease Genetic host susceptibility
Non pathogenic commensal enteric flora.
132
Pathophysiology of Chrons disease Pathologic hallmark
Focal trans mural inflammation of the intestine
133
Other pathologic lesions of chrons disease Earliest lesions characterized
Aphthous ulcer Arise over lymphoid aggregates
134
Other pathologic lesions of chrons disease Highly characteristic of chrons disease
Granulomas Noncaseating Found in any layer of the bowel wall and mesenteric lymph node
135
Other pathologic lesions of chrons disease Form as disease progresses, aphthae coalesce into larger ulcers.
STELLATE-SHAPED ULCERS
136
Chrons disease Form when multiple ulcers fuse in a direction parallel to the longitudinal axis of the intestine.
LINEAR OR SERPIGINOUS ULCERS
137
Chrons disease Form with transverse coalescence of ulcers
COBBLESTONE MUCOSA
138
Chrons disease * Occurs with advanced disease. * Serosal involvement results in adhesion of the inflamed bowel to other loops of bowel or other adjacent organs.
Transmural inflammation
139
Chrons disease •Inflammation in Crohn's disease can affect discontinuous portions of intestine: so-called skip lesions that are separated by intervening normal appearing intestine.
SKIP LESIONS
140
Chrons disease morphology symptoms
Christmas
141
Crowns disease * A feature of Crohn's disease that is grossly evident and helpful in identifying affected segments of intestine during surgery. * Encroachment of mesenteric fat onto the serosal surface of the bowel * This finding is virtually pathognomonic of Crohn's disease.
Fat wrapping
142
•Layers of the bowel wall affected: Ulcerative and chrons
UC: Limited to mucosa and submucosa | •CD: May involve the full thickness of the bowel wall
143
•Longitudinal extent of inflammation Ulcerative colitis and chrons
UC: Inflammation is continuous and affects the rectum | •CD: May be discontinuous and spares the rectum
144
It is also important to remember that, although ulcerative colitis is a disease of the colon, it can be associated with inflammatory changes in the distal ileum
Backwash ileitis
145
The most common symptoms of Crohn's disease are
abdominal pain, diarrhea, and weight loss
146
•Patients with Crohn's disease can be classified by their PREDOMINANT clinical manifestation:
a) fibrostenotic disease (b) fistulizing disease (c) aggressive inflammatory disease.
147
•Constitutional symptoms, particularly _______________________________, may also be prominent and are occasionally the sole presenting features of Crohn's disease.
weight loss and fever, or growth retardation in children
148
Crohn's disease •The disease affects the small bowel in 80% of cases and majority have
ileocecal disease.
149
Crohn's disease •Uncommon sites of involvement include the
esophagus, stomach, and duodenum.
150
•An estimated one fourth of all patients with Crohn's disease will have an _______________ of their disease.
EXTRAINTESTINAL MANIFESTATION
151
Diagnosis of Crohn's disease
No single symptom, sign, or diagnostic test establishes the diagnosis of Crohn's disease.
152
Dx Crohn's disease •Main diagnostic tool Can reveal focal ulcerations adjacent to areas of normal appearing mucosa along with polypoid mucosal changes that give a "cobblestone appearance." •Skip areas of involvement are typical. •Pseudopolyps, as seen in ulcerative colitis, are also often present.
COLONOSCOPY with intubation of terminal ileum
153
Dx of Crohn's disease •May reveal strictures or networks of ulcers and fissures.
•2)CONTRAST EXAMINATIONS of the small bowel and colon:
154
Dx of Crohn's disease * May reveal intra-abdominal abscesses * Useful in acute presentations to rule out the presence of other intra-abdominal disorders.
•3)CT SCANNING:
155
Dx of Crohn's disease •Is done for disease of the proximal alimentary tract.
4)ESOPHAGOGASTRODUODENOSCOPY (EGD)
156
Dx of Crohn's disease * Has been increasingly used because Crohn's disease often affects the small bowel, which is difficult to image. * Capsule endoscopy is a technology that uses a swallowed video capsule to take photographs of the inside of the esophagus, stomach, and small intestine.
5)CAPSULE ENDOSCOPY
157
* 5)CAPSULE ENDOSCOPY * Large capsule-larger than the largest pill-is swallowed by the patient. * The capsule contains one or two video chips (cameras), a light bulb, a battery, and a radio transmitter. * As the capsule travels through the esophagus, stomach, and small intestine, it takes photographs rapidly. * The photographs are transmitted by the radio transmitter to a small receiver that is worn on the waist of the patient who is undergoing the capsule endoscopy. * At the end of the procedure, approximately 24 hours later, the photographs are downloaded from the receiver into a computer, and the images are reviewed by a physician. * The capsule is passed by the patient into the toilet and flushed away.
Nice to know
158
- is associated with a diagnosis of Crohn's disease
ASCA+/pANCA
159
+ is correlated with ulcerative colitis.
ASCA–/pANCA
160
•Because of the insidious, and often, nonspecific presentation, the diagnosis of Crohn's disease typically is made only after symptoms have been present for .
several years
161
•The initial manifestation of Crohn's disease can consist of
right lower quadrant pain mimicking acute appendicitis.
162
* In some patients, the initial manifestation of Crohn's disease is an acute abdomen related to small bowel obstruction, intra-abdominal abscess, or free intestinal perforation. * In other patients, perianal abscesses and fistulas requiring surgical therapy may be the first manifestation of Crohn's disease.
Nice to know
163
Management of Crohn's disease
* NO curative therapies are available for Crohn's disease. * GOAL of treatment is to palliate symptoms rather than to achieve cure. * Medical therapy is used to induce and maintain disease remission. * Surgery is reserved for specific indications.
164
Crohn's disease 1)ANTIBIOTICS:for treatment of:
Infectious complications associated with Crohn's disease * Perianal disease * Enterocutaneous fistulas * Active colonic disease
165
Crohn's disease • •Have shown to be superior to placebo in inducing disease remission. •Its efficacy in the maintenance of remission is less clear.
Oral 5-aminosalicylic acid (5-ASA) drugs (e.g., mesalamine):
166
Crohn's disease * Parent compound of 5-ASA * Widely used in UC but has been shown to be less effective than 5-ASA in CD.
Sulfasalazine
167
Crohn's disease •For patients with mildly to moderately severe disease that does not respond to aminosalicylates.
Oral glucocorticoids:
168
Crohn's disease * For patients with severe active disease. * Are effective in inducing remission, but are ineffective in preventing relapse * Their adverse side-effect profile makes long-term use hazardous. Therefore, they should be tapered once remission is achieved.
IV glucocorticoids:
169
Crohn's disease Some patients are unable to undergo glucocorticoid tapering without suffering recurrence of symptoms. Such patients are said to have
STEROID DEPENDENCE.
170
Crohn's disease For STEROID-DEPENDENT patients, along with those who do not respond to steroids at all (STEROID RESISTANT) patients, use of ______________ should be considered
immune modulators
171
Crohn's disease * Effective in inducing remission, in maintaining remission, and in allowing for glucocorticoid tapering in glucocorticoid-dependent patients. * Response to the medications is usually observed in 3 to 6 months. * they can decrease the risk of relapse after intestinal resection for Crohn's
4)IMMUNOMODULATORS: •THIOPURINE ANTIMETABOLITES: •Azathioprine and its active metabolite, 6-mercaptopurine
172
* 4)IMMUNOMODULATORS:(Cont.) * THIOPURINE ANTIMETABOLITES: * SE:
can induce bone marrow suppression and promote infectious complications.
173
•For patients who do not respond to the thiopurines, _____________ is an alternative that usually is given IM before switching to oral form after achieving symptomatic control.
methotrexate
174
•There is little role for cyclosporine in Crohn's disease; its efficacy/toxicity profile in this disease is poor.
Nice to know
175
* Chimeric monoclonal anti–tumor necrosis factor α-antibody * Has shown to have efficacy in inducing remission and in promoting closure of enterocutaneous fistulas. * It generally is used for patients resistant to standard therapy to help taper steroid dosage.
Infliximab
176
•Infliximab generally is well tolerated but should not be used in patients with ongoing septic processes, such as
undrained intra-abdominal abscesses.
177
Crohn's disease * For patients with PERIANAL DISEASE: * __________________________ is the primary step. * Two to 4 weeks of therapy is needed before improvements are seen, and often long-term therapy is required to prevent relapse.
METRONIDAZOLE or CIPROFLOXACIN
178
In cases of relapse: ____________ can be considered.
AZATHIOPRINE
179
•In patients with fistulas: _________ and AZATHIOPRINE are drugs of choice.
INFLIXIMAB
180
Surgical treatment of Crohn's disease
* Fifty to 70% of patients with Crohn's disease will ultimately require at least one surgical intervention for their disease. * Surgery generally is reserved for patients whose disease is unresponsive to aggressive medical therapy or who develop complications of their disease. * FAILURE of medical management may be the indication for surgery if symptoms persist despite aggressive therapy for several months or if symptoms recur whenever aggressive therapy is tapered.
181
Crohn's disease One of the most common indications for surgical intervention
Intestinal obstruction
182
Crohn's disease ______________ frequently are encountered during operations performed for intestinal obstruction.
Abscesses and fistulas
183
Crohn's disease unless associated with symptoms or metabolic derangements do not require surgical intervention.
Fistulas
184
* INTRAOPERATIVE DISCOVERY OF INFLAMMATION LIMITED TO TERMINAL ILEUM ("TERMINAL ILEITIS") during operations performed for presumed appendicitis. * An uncommon but not rare scenario in patients with Crohn's disease. * This scenario can result from: * An acute presentation of Crohn's disease or * From acute ileitis caused by bacteria such as
Yersinia or Campylobacter.
185
* The usual procedure of choice for grossly evident disease. * Microscopic evidence of Crohn's disease at the resection margins does not compromise a safe anastomosis, and frozen-section analysis of resection margins is unnecessary. * Recurrence rates were similar whether margins were histologically free of or involved with Crohn's disease.
SEGMENTAL RESECTION AND PRIMARY ANASTOMOSIS:
186
: •Alternative to segmental resection for obstructing lesions is stricturoplasty * This technique allows for preservation of intestinal surface area * Well-suited for patients with extensive disease and fibrotic strictures who may have undergone previous resection and are at risk for developing short bowel syndrome. * In this technique, the bowel is opened LONGITUDINALLY to expose the lumen. Any intraluminal ulcerations should be biopsied to rule out the presence of neoplasia.
STRICTUROPLASTY
187
Crohn's disease •For strictures less than 12 cm in length)
HEINECKE-MICULICZ PYLOROPLASTY type of repair:
188
Crohn's disease •For longer strictures as much as 25 cm in length
FINNEY PYLOROPLASTY type of repair:
189
Crohn's disease •For longer strictures, with mean lengths of 50 cm.
ISOPERISTALTIC ENTEROENTEROSTOMY (side to side)
190
Crohn's disease * Are sometimes required in the presence of intramesenteric abscesses or if the diseased bowel is coalesced in the form of a dense inflammatory mass, making its mobilization unsafe. * Bypass procedures (gastrojejunostomy) also are used in the presence of duodenal strictures, for which stricturoplasty and segmental resection can be technically difficult.
INTESTINAL BYPASS PROCEDURES:
191
Outcomes of chrons disease
•Overall complication rates following surgery for Crohn's disease: range from 15 to 30%. * SURGICAL COMPLICATIONS include: * Wound infections * Postoperative intra-abdominal abscesses * Anastomotic leaks OUTCOMES of CROHN'S DISEASE
192
* CLINICAL RECURRENCE: * Defined as the return of symptoms confirmed as being due to Crohn's disease, affects 60% of patients by 5 years and 94% by 15 years after intestinal resection. •REOPERATION becomes necessary in approximately one third of patients by 5 years after the initial operation, with a median time to reoperation of 7 to 10 years.
Nice to know
193
Embryology Primitive GUT appears
4th week of gestation